Mohamad Baraa Alebaji

3PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 28, 2026
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408.

Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura

|Sep 17, 2024
Uncovering the Hidden Cause of Recurrent Chest Infections in a Child: A Case Report.

Mohamad Baraa Alebaji, Shoroogh Marie, Najla Al Kuwaiti

|Apr 23, 2022
Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.

Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura

Pageof 1

Frequent Collaborators

2 joint publications

Khuloud Bajbouj

2 joint publications

Zeinab Ibrahim

2 joint publications

Maha M Saber-Ayad

2 joint publications

Adel B Elmoselhi